mDCs, defined as CD3-CD14-CD19-CD56-CD11c+HLA-DR+ cells (Figure 4A), displayed a sharply reduced frequency in blood from treatment-naïve CVID patients (Figure 4B). The gene discussed is CD14; the disease is common variable immunodeficiency.